Diagnostic screening programs help catch cancer, abnormalities or other diseases before they reach an advanced stage, saving lives and healthcare costs. Screening programs include, lung, breast, prostate, and cervical cancer, among many others.
Ultrasound is routinely used to screen for HCC. However, its utility is limited by numerous factors, including patient body habitus, operator experience and certain liver conditions, all of which contribute to decreases in sensitivity.
In conjunction with prevention efforts, the introduction of screening examinations has resulted in a reduction of nearly 6 million cancer-related deaths since 1975.
Breast density is most often discussed within the context of cancer risk, but new research suggests that it also could be used as a marker of cardiometabolic health.
The newly cleared offering, AutoChamber, was designed with opportunistic screening in mind. It can evaluate many different kinds of CT images, including those originally gathered to screen patients for lung cancer.
Clinical information systems provider Creative Computer Applications Inc. (CCA) has announced its intent to merge with StorCOMM Inc. of Jacksonville, Fla., a private company providing PACS and clinical image management systems.
Fluke Biomedical Radiation Management Services (formerly Cardinal Health Inc.) introduced the Victoreen Advanced Survey Meter ASM 990 Series Wipe Test Fixture, which enables the ASM 990 to detect removable radioactive contamination.
Mayo Foundation of Rochester, Minn., has inked a five-year agreement with healthcare cooperative VHA Inc., renewing the pair's partnership formed in 2000.
With repetitive stress injuries already chronic among many sonographers and procedure volumes continuing to climb, a wide variety of ultrasound system vendors are offering more human-centric, ergonomically sound units.
RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.
Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.
A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.
